Summary of Product Characteristics
last updated on the eMC:
10/11/2010
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 10/11/2010 and displayed until Current
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
| Date of revision of text on the SPC: 01-May-2010 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| None provided |
|
Updated on 11/06/2010 and displayed until 10/11/2010
|
Reasons for adding or updating:
|
-
Change to section 2 - Qualitative and quantitative composition
-
Change to section 4.4 - Special warnings and precautions for Use
-
Change to section 5.1 - Pharmacodynamic Properties
-
Change to section 6. 6 - Instructions for use, handling and disposal
-
Change to section 9 - Date of first Authorisation/renewal of the Authorisation
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 01-May-2010 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
In section 2.2 (Qualitative and Quantiative Composition) the following text has been added: "Excipient : Propylene glycol 2.0% w/w"
In section 4.4 (Special warnings and precautions for use) the following text has been added: "The excipient propylene glycol may on rare occasions cause skin irritation in sensitive people."
In section 5.1 (Pharmacodynamic properties) the following text has been added: "ATC code : M02A A13, Antiinflammatory preparations, non-steroids for topical use."
In section 6.6 (Special precautions for disposal and other handling) the text has changed to "No special requirements"
In section 9 (Renewal of the authorisation) the date has changed to "12 January 2009"
In section 10 (Date of revision of the text) the date has changed to "May 2010"
|
|
Updated on 08/02/2008 and displayed until 11/06/2010
|
Reasons for adding or updating:
|
-
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
|
| Date of revision of text on the SPC: 10/2007 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Section 4.5 - Interactions with other medicinal products and other forms of interaction: Additional text in bold has been added, as follows: " ... blood pressure lowering drugs, any may possibly enhance the effects of anticoagulants, although the chance of either of these occurring with a topically administered preparation is extremely remote."
|
|
Updated on 26/01/2007 and displayed until 08/02/2008
|
Reasons for adding or updating:
|
-
New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
|
|